<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C754D612-4D8B-42CB-922C-07E7F5BE4B49"><gtr:id>C754D612-4D8B-42CB-922C-07E7F5BE4B49</gtr:id><gtr:name>Washington University in St. Louis</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/EBD1FA4C-E8B2-48AE-A1CC-D1090B88D55A"><gtr:id>EBD1FA4C-E8B2-48AE-A1CC-D1090B88D55A</gtr:id><gtr:name>Nyumbani Orphanage</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/31AF7C42-D7C4-47FF-A5D8-19AADBAD30A9"><gtr:id>31AF7C42-D7C4-47FF-A5D8-19AADBAD30A9</gtr:id><gtr:name>MRC Human Immunology Unit</gtr:name><gtr:address><gtr:line1>Weatherall Inst of Molecular Medicine</gtr:line1><gtr:line2>John Radcliffe Hospital</gtr:line2><gtr:line3>Headington</gtr:line3><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 9DS</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/31AF7C42-D7C4-47FF-A5D8-19AADBAD30A9"><gtr:id>31AF7C42-D7C4-47FF-A5D8-19AADBAD30A9</gtr:id><gtr:name>MRC Human Immunology Unit</gtr:name><gtr:address><gtr:line1>Weatherall Inst of Molecular Medicine</gtr:line1><gtr:line2>John Radcliffe Hospital</gtr:line2><gtr:line3>Headington</gtr:line3><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 9DS</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C754D612-4D8B-42CB-922C-07E7F5BE4B49"><gtr:id>C754D612-4D8B-42CB-922C-07E7F5BE4B49</gtr:id><gtr:name>Washington University in St. Louis</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EBD1FA4C-E8B2-48AE-A1CC-D1090B88D55A"><gtr:id>EBD1FA4C-E8B2-48AE-A1CC-D1090B88D55A</gtr:id><gtr:name>Nyumbani Orphanage</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/EE698B07-6C45-47E9-A637-420AD61D5494"><gtr:id>EE698B07-6C45-47E9-A637-420AD61D5494</gtr:id><gtr:firstName>Tao</gtr:firstName><gtr:surname>Dong</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/23D47341-B294-4027-B1ED-1C5C81B5B51E"><gtr:id>23D47341-B294-4027-B1ED-1C5C81B5B51E</gtr:id><gtr:firstName>Sarah</gtr:firstName><gtr:otherNames>Louise</gtr:otherNames><gtr:surname>Rowland-Jones</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U137884180"><gtr:id>52A15E26-9961-41EA-84DF-2C2B8D3180CB</gtr:id><gtr:title>The cellular immune response to HIV-1, HIV-2, influenza and Dengue virus infection</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U137884180</gtr:grantReference><gtr:abstractText>AIM1: a) nature of research - The aim of this research is to understand how the immune response to HIV infection can succeed in controlling the virus in people who show few signs of disease progression despite many years of HIV infection. We are also examining why the immune response eventually fails in late disease. We hope that these studies will provide important clues about the best way of designing an HIV vaccine. In addition we are trying to understand the details of the immune response in people from different parts of the world exposed to different HIV strains to improve the design of vaccines for China and Africa.||b) prospective outcomes - Clearer understanding of anti-viral immunity to HIV-1 and HIV-2.||c) health benefits - Improved management of HIV infections in developed and developing countries ||AIM 2: a) Nature of research - The aim of this study is to study how the human body can respond to human and avian influenza virus infection, focusing specifically on killer T-cells that kill influenza-virus-infected cells. We are looking at how big these T cell responses are and whether they react only to avian virus - or will people whose T-cells recognise the common flu strains have some protection against avian flu? Do these T-cell responses play a part in protecting people who have been exposed to avian flu but who did not become sick? Or is there a possibility that having T-cell immunity to the more common influenza virus strains could actually cause disease in people who are exposed to avian strains of influenza A virus?||b) prospective outcomes-clearer understanding of the role of influenza specific T cells played in human and avian influenza infection||c) health benefits - The study of Avian Influenza virus memory T cells responses in H5N1 virus infected patients will tell us if influenza specific memory T cells play a part in the protection or pathogenesis of avian influenza infection of humans, which is very crucial for future Vaccine design against avian influenza virus infection.</gtr:abstractText><gtr:technicalSummary>Summary and aims of project||AIM 1 (Main): anti-viral immunity to HIV-1 and HIV-2. The aim of this research is to understand the key components of the cellular immune response to HIV infection, focusing particularly on patients with an unusually good outcome of their encounter with HIV infection - particularly those long term non-progressors who have been infected with HIV for 10 years or more but remain asymptomatic with no signs of immune deficiency. ||We are examining the cellular immune mechanisms that may correlate with control of disease progression, looking at methods whereby the immune system can be restored in HIV infection and preparing for vaccine studies in developing countries by studying the cellular immune responses to African and Chinese HIV-1 strains. ||The work involves detailed T cell functional studies in different patient cohorts: ||a) HIV-2 infected long-term non-progressors, who account for most (around 80%) HIV infected patients in West Africa: these studies are carried out in collaboration with the Gambia MRC Unit.||b) Long term non-progressors with HIV-1 infection (less than 2% HIV-1 infected individuals), in collaboration with Prof. Easterbrook in Kings College, London and Dr Chris Conlon, Oxford||c) infants exposed to HIV at birth and through breast-feeding by HIV infected mothers, in collaboration with Nairobi University, Kenya and University of Washington, USA||d) HIV infected plasma donors in China, in collaboration with BeiJing Youan and DiTan infectious disease Hospitals ||AIM 2: The role played by influenza-specific T cells in human and Avian flu infection in Vietnam - in collaboration with Prof. Jeremy Farrar, Wellcome Trust Unit in Vietnam.||The aim of the study is to measure the H5N1 avian influenza virus specific T cell responses, examining cross reactivity for virus subtypes, in both acutely infected and convalescent patients infected with either H5N1 avian influenza virus or and H3N2/H1N1 virus in Vietnam. We are monitoring the functional changes in T cell memory pools longitudinally, to study if the quality of the dominant T cell responses has an impact on the clinical outcome of H5N1 human infection.||We are also examining T cell responses in people who have been exposed to avian influenza virus but who did not become sick, looking for evidence of sub clinical infection and immunity. These studies will help us to understand the role of T cell immune responses in avian influenza A and give us a better understanding of whether memory T cells contribute to protective immunity or to disease pathogenesis. ||These studies will have important implications for future vaccine strategies for pandemic influenza. The influenza virus specific T cell epitopes that are identified and characterised in this study will also be important for the design and evaluation of T cell inducing Vaccines for influenza A.||Experimental design - Patient studies, epidemiology, vaccine trials||a) tissues, cells, animals used - human CTL studies, cervico-vaginal washings, gamma interferon measurements||b) techniques/approaches - Cellular Immunology||c) measurements/outcomes - Restoration of immune function in HIV infection</gtr:technicalSummary><gtr:fund><gtr:end>2010-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1998-10-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>2389596</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Nyumbani Orphanage</gtr:collaboratingOrganisation><gtr:country>Kenya, Republic of</gtr:country><gtr:description>Oxford/Nyumbani collaboration</gtr:description><gtr:id>DCF8142E-E36C-421E-A1AC-D4B2EDB7822E</gtr:id><gtr:impact>joint publications</gtr:impact><gtr:outcomeId>23774BA3562-1</gtr:outcomeId><gtr:partnerContribution>The Orphanage Director, Father d'Agostino prepared a research protocol with our group to investigate long-term non-progression in vertically HIV-infected adolescents and provided clinical and logistical support to a research fellow who carried out the study.</gtr:partnerContribution><gtr:piContribution>We provided financial support to the orphanage, including assistance with laboratory tests (such as viral loads and CD4 counts). Dr Chakraborty was an MRC training fellow and paediatrician who did his PhD as part of this collaboration and provided clinical care for the children in the orphanage.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>Vietnam, Socialist Republic of</gtr:country><gtr:department>Oxford University Clinical Research Unit Vietnam (OUCRU)</gtr:department><gtr:description>Oxford VietNam collaboration on dengue virus infection</gtr:description><gtr:id>3A73D852-6652-45C1-8CDB-A27BBE51FD8A</gtr:id><gtr:impact>PhD awarded to Dr Nguyen Vinh Chau
Joint publications</gtr:impact><gtr:outcomeId>ct7AXfpaFCP-1</gtr:outcomeId><gtr:partnerContribution>Collaborative studies on dengue virus and avian influenza infection. Provision of patient samples with clinical and epidemiological data. Hosting visits by Oxford students and post-docs and provision of laboratory facilities.</gtr:partnerContribution><gtr:piContribution>Training of Vietnamese students for specialist techniques in Oxford. Co-supervision of a Vietnamese PhD student. Provision of peptide-HLA tetrameric complexes for T-cell studies in Vietnam</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Washington</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Oxford/U. Washington HIV partnership</gtr:description><gtr:id>7871EB4E-31AA-4D27-9FED-0E6099BEDCC3</gtr:id><gtr:impact>Joint publications</gtr:impact><gtr:outcomeId>A65D8BF3D01-1</gtr:outcomeId><gtr:partnerContribution>We have jointly applied for NIH funding (PI Dr Grace John-Stewart) and received an R01 award, of which approximately $400,000 was in the form of a subcontract from UW to our group (1999-2005). Our collaborators have provided clinical and epidemiological support to our research studies in Nairobi and we have jointly supervised a PhD student.</gtr:partnerContribution><gtr:piContribution>We have provided training in cellular and molecular immunology techniques for Kenyan and US students, post-docs and technicians engaged in this collaboration and joint supervision of a PhD student (Jenn Slyker, completed PhD 2007).</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Public Lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>3E0FB1AA-54EB-45FC-B7CC-456492DCB8E0</gtr:id><gtr:impact>I presented a talk about my research in the context of HIV vaccine development as part of the BSI's annual meeting in Glasgow.

Not known.</gtr:impact><gtr:outcomeId>0D6A7309F17</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>486559</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Strategic Grant</gtr:description><gtr:end>2012-01-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>62EF0747-A804-45BB-A65E-3544FD497580</gtr:id><gtr:outcomeId>E3C26E12AFB0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>191285</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Clinical Training fellowship (Dr Moran)</gtr:description><gtr:end>2007-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>9E51181B-97F9-48AA-A051-87852CC34B60</gtr:id><gtr:outcomeId>F6590A10B670</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>280000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust clinical training fellowship (Dr Elham Khatamzas)</gtr:description><gtr:end>2011-07-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>8238D9D8-AC8D-479A-90BA-09F194FEF59C</gtr:id><gtr:outcomeId>E64AC35FCC40</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>412500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Influenza A call for proposals</gtr:description><gtr:end>2010-02-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>F81A03E5-15C2-4084-B023-D62AB22159A0</gtr:id><gtr:outcomeId>qTM2bgyqVmL0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-06-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>D76C2BD1-0188-470E-8F59-8223FB7CE148</gtr:id><gtr:title>Modified vaccinia Ankara expressing HIVA antigen stimulates HIV-1-specific CD8 T cells in ELISpot assays of HIV-1 exposed infants.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/53ec73e089aeac247def8f542613a45d"><gtr:id>53ec73e089aeac247def8f542613a45d</gtr:id><gtr:otherNames>Slyker JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>D6A9F5A575C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D179BDED-FDEF-44CB-87E9-3686435D2AD9</gtr:id><gtr:title>Robust Gag-specific T cell responses characterize viremia control in HIV-2 infection.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c0ae9c03e19152fa146debeb3e0a9814"><gtr:id>c0ae9c03e19152fa146debeb3e0a9814</gtr:id><gtr:otherNames>Leligdowicz A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>C87443A5106</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DED9A866-89AC-4E4C-B565-C304DC564644</gtr:id><gtr:title>Dendritic cells are less susceptible to human immunodeficiency virus type 2 (HIV-2) infection than to HIV-1 infection.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f90a66fcd9ab2ce6df6436b14b4eb6d"><gtr:id>6f90a66fcd9ab2ce6df6436b14b4eb6d</gtr:id><gtr:otherNames>Duvall MG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>DA908EF4E43</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8AD0B1E0-C908-44A6-BAFF-DAA6698BA6E2</gtr:id><gtr:title>Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8428373b18bd0a52b3e33311d03b3321"><gtr:id>8428373b18bd0a52b3e33311d03b3321</gtr:id><gtr:otherNames>Lee LY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>D29B7FA512B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>618F156E-75B4-48D7-B6D5-295F817BE8EF</gtr:id><gtr:title>Acute cytomegalovirus infection in Kenyan HIV-infected infants.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/53ec73e089aeac247def8f542613a45d"><gtr:id>53ec73e089aeac247def8f542613a45d</gtr:id><gtr:otherNames>Slyker JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>F745E80923B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>743C8B94-F503-4B1C-A40B-7BD70EBF26FC</gtr:id><gtr:title>The detection of cytomegalovirus DNA in maternal plasma is associated with mortality in HIV-1-infected women and their infants.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/53ec73e089aeac247def8f542613a45d"><gtr:id>53ec73e089aeac247def8f542613a45d</gtr:id><gtr:otherNames>Slyker JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>7659FDA307B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B5E90CC9-9F58-42F9-B5C0-ED251FD8FAB6</gtr:id><gtr:title>Immune reconstitution inflammatory syndrome and the influence of T regulatory cells: a cohort study in The Gambia.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d1bd6f250b0486d8e2467c652215b64"><gtr:id>2d1bd6f250b0486d8e2467c652215b64</gtr:id><gtr:otherNames>Zaidi I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_15867_27_22745716</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>728FE84C-0A6B-4E22-A21D-DFF90311A7CC</gtr:id><gtr:title>Dying T cells trigger autoimmunity in HIV.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b50de85793ff82e009c06fac08918e7"><gtr:id>9b50de85793ff82e009c06fac08918e7</gtr:id><gtr:otherNames>Rowland-Jones S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn><gtr:outcomeId>7C4E70A5925</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ABAED86C-D2B2-4B63-B2C5-381643EB5027</gtr:id><gtr:title>Comprehensive analysis of HIV Gag-specific IFN-gamma response in HIV-1- and HIV-2-infected asymptomatic patients from a clinical cohort in The Gambia.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0176ac52f7a3858de3221c9d5a7dfd0a"><gtr:id>0176ac52f7a3858de3221c9d5a7dfd0a</gtr:id><gtr:otherNames>Ondondo BO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>F4E3AE400C0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CEF2DA84-6F00-45A3-AC65-627689276193</gtr:id><gtr:title>Immunisation with recombinant modified vaccinia virus Ankara expressing HIV-1 gag in HIV-1-infected subjects stimulates broad functional CD4+ T cell responses.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0176ac52f7a3858de3221c9d5a7dfd0a"><gtr:id>0176ac52f7a3858de3221c9d5a7dfd0a</gtr:id><gtr:otherNames>Ondondo BO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>8C2A4F92D99</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>21410A2E-0A16-4612-A1A0-7E979CB5F0F5</gtr:id><gtr:title>Mortality and immunovirological outcomes on antiretroviral therapy in HIV-1 and HIV-2-infected individuals in the Gambia.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f4aab35f65c58e64f6df1af9bd93169d"><gtr:id>f4aab35f65c58e64f6df1af9bd93169d</gtr:id><gtr:otherNames>Peterson I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>deortzSRmyH</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>138999E1-7E28-4B8D-A37A-50495E1FAED7</gtr:id><gtr:title>T-cell immunity to Kaposi sarcoma-associated herpesvirus: recognition of primary effusion lymphoma by LANA-specific CD4+ T cells.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f5dac7f19ae78980fe985938e68ca20"><gtr:id>8f5dac7f19ae78980fe985938e68ca20</gtr:id><gtr:otherNames>Sabbah S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>pm_15867_27_22234686</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3B83CA0E-2079-45D8-AA21-AF844B6F2294</gtr:id><gtr:title>Genomic analysis of HIV type 1 strains derived from a mother and child pair of long-term nonprogressors.</gtr:title><gtr:parentPublicationTitle>AIDS research and human retroviruses</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f58637a47b80a72db4dd6734286394d"><gtr:id>6f58637a47b80a72db4dd6734286394d</gtr:id><gtr:otherNames>Reinis M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0889-2229</gtr:issn><gtr:outcomeId>B46FF18EC19</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A3954177-2006-424E-A609-9CB89E1262C3</gtr:id><gtr:title>Effect of HIV-2 infection on HIV-1 disease progression.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/292540540153f0fec29df5f22db2aecf"><gtr:id>292540540153f0fec29df5f22db2aecf</gtr:id><gtr:otherNames>de Silva T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>pm_15867_27_23150974</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C3830E08-1B00-4EEB-8794-7C7AB8775D78</gtr:id><gtr:title>CCR2-64I polymorphism is associated with lower maternal HIV-1 viral load and reduced vertical HIV-1 transmission.</gtr:title><gtr:parentPublicationTitle>Journal of acquired immune deficiency syndromes (1999)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1a36a70590e9e107a94d4a69fad3c938"><gtr:id>1a36a70590e9e107a94d4a69fad3c938</gtr:id><gtr:otherNames>Mabuka JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1525-4135</gtr:issn><gtr:outcomeId>1C483D188A2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CE6ECA7B-A3F9-4CCE-81F0-B6B24E007E66</gtr:id><gtr:title>Population dynamics of HIV-2 in rural West Africa: comparison with HIV-1 and ongoing transmission at the heart of the epidemic.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c7219e699c28c45d6e339476809f7f10"><gtr:id>c7219e699c28c45d6e339476809f7f10</gtr:id><gtr:otherNames>de Silva TI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>pm_15867_27_23032414</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F58BE31F-75B8-445E-A6CF-DCE291405F0E</gtr:id><gtr:title>Epitope mapping of broadly neutralizing HIV-2 human monoclonal antibodies.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fe865d72018863f6adc6388cb17f05c"><gtr:id>0fe865d72018863f6adc6388cb17f05c</gtr:id><gtr:otherNames>Kong R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>pm_15867_27_22933274</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>07C71397-DE2B-4342-994A-EF42ECB7BC6A</gtr:id><gtr:title>Timing of CD8+ T cell responses in relation to commencement of capillary leakage in children with dengue.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7565951b0f0ca59c1de7afa1663bc589"><gtr:id>7565951b0f0ca59c1de7afa1663bc589</gtr:id><gtr:otherNames>Dung NT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>igKPVvptXvu</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C13F593A-A24C-4C68-8DD2-C7AB83DF4AB7</gtr:id><gtr:title>Maintenance of HIV-specific CD4+ T cell help distinguishes HIV-2 from HIV-1 infection.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f90a66fcd9ab2ce6df6436b14b4eb6d"><gtr:id>6f90a66fcd9ab2ce6df6436b14b4eb6d</gtr:id><gtr:otherNames>Duvall MG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>C1201F204E5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FCF46E9D-1E0B-42FD-8595-26304251FC31</gtr:id><gtr:title>Characterization of Melan-A reactive memory CD8+ T cells in a healthy donor.</gtr:title><gtr:parentPublicationTitle>International immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/587809cbdc3ef889dffae0c065bf1b3f"><gtr:id>587809cbdc3ef889dffae0c065bf1b3f</gtr:id><gtr:otherNames>Voelter V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0953-8178</gtr:issn><gtr:outcomeId>9C48F511ABA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3F3011B2-0027-4D44-BE58-CA36BB1BB360</gtr:id><gtr:title>Clinical predictors cannot replace biological predictors in HIV-2 infection in a community setting in West Africa.</gtr:title><gtr:parentPublicationTitle>International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b24ec7623b969cce808560f0704b0bbf"><gtr:id>b24ec7623b969cce808560f0704b0bbf</gtr:id><gtr:otherNames>Gourlay AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1201-9712</gtr:issn><gtr:outcomeId>pm_15867_27_22387142</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4BEC5722-CC87-4253-B354-FD54F3352E1F</gtr:id><gtr:title>Identification of a novel HLA B*57 restricted cytotoxic T-lymphocyte epitope within HIV-1 rev.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/193c31d7dd0cbcc9e1cc55671bfe06d2"><gtr:id>193c31d7dd0cbcc9e1cc55671bfe06d2</gtr:id><gtr:otherNames>Makadzange AT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>198541929DE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0CDDE0AD-D78B-473C-8DA0-90D0ECE462B2</gtr:id><gtr:title>Lack of KIR3DS1 binding to MHC class I Bw4 tetramers in complex with CD8+ T cell epitopes.</gtr:title><gtr:parentPublicationTitle>AIDS research and human retroviruses</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f5491b386d455aa4032571d48e83937"><gtr:id>6f5491b386d455aa4032571d48e83937</gtr:id><gtr:otherNames>Gillespie GM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0889-2229</gtr:issn><gtr:outcomeId>19227D519F1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A3D09F22-7640-47ED-A8F3-EF3A4FDCFA12</gtr:id><gtr:title>Out of Africa: what can we learn from HIV-2 about protective immunity to HIV-1?</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cdfccf93dde20c9fcbf00a81bfb61234"><gtr:id>cdfccf93dde20c9fcbf00a81bfb61234</gtr:id><gtr:otherNames>Rowland-Jones SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>0A5BA479F3C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0081D670-C81E-45BF-8D9B-C6006C5CBFB5</gtr:id><gtr:title>Characterization of an HLA-C-restricted CTL response in chronic HIV infection.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/193c31d7dd0cbcc9e1cc55671bfe06d2"><gtr:id>193c31d7dd0cbcc9e1cc55671bfe06d2</gtr:id><gtr:otherNames>Makadzange AT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>hHkjejJsMx1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3C9B9E0E-AB6A-459E-83B5-A720C7861F82</gtr:id><gtr:title>Deep analysis of cellular transcriptomes - LongSAGE versus classic MPSS.</gtr:title><gtr:parentPublicationTitle>BMC genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1989745519960506e8aa547c2729a823"><gtr:id>1989745519960506e8aa547c2729a823</gtr:id><gtr:otherNames>Hene L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1471-2164</gtr:issn><gtr:outcomeId>EF2FBF06012</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>40C86ECE-1850-4476-B429-228C73EB4656</gtr:id><gtr:title>Structures of three HIV-1 HLA-B*5703-peptide complexes and identification of related HLAs potentially associated with long-term nonprogression.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d074abc03c715ec0a4b00eddac6d3810"><gtr:id>d074abc03c715ec0a4b00eddac6d3810</gtr:id><gtr:otherNames>Stewart-Jones GB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>B867A84B92C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>06370C4D-958B-457A-84D9-A5A36F9FDF52</gtr:id><gtr:title>Preservation of a critical epitope core region is associated with the high degree of flaviviral cross-reactivity exhibited by a dengue-specific CD4+ T cell clone.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e9a10402586c7045c52bbc997543dc29"><gtr:id>e9a10402586c7045c52bbc997543dc29</gtr:id><gtr:otherNames>Moran E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>793E58B49F2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>081E6963-CCF6-4B5A-B364-E6BA5F6C686F</gtr:id><gtr:title>Dimorphic motifs in D0 and D1+D2 domains of killer cell Ig-like receptor 3DL1 combine to form receptors with high, moderate, and no avidity for the complex of a peptide derived from HIV and HLA-A*2402.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c3275c0cec940b6296fd12f18574b05e"><gtr:id>c3275c0cec940b6296fd12f18574b05e</gtr:id><gtr:otherNames>Sharma D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>E37D8EB06DC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A7692D2-4125-4DD5-902B-4D635F66F90E</gtr:id><gtr:title>Strong TCR conservation and altered T cell cross-reactivity characterize a B*57-restricted immune response in HIV-1 infection.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f5491b386d455aa4032571d48e83937"><gtr:id>6f5491b386d455aa4032571d48e83937</gtr:id><gtr:otherNames>Gillespie GM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>3A5F5FDEF8A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>01F2629B-06D6-4F83-8444-66519C7AAAE6</gtr:id><gtr:title>Differential remodeling of a T-cell transcriptome following CD8- versus CD3-induced signaling.</gtr:title><gtr:parentPublicationTitle>Cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eb045eb004a69a1506f1d58c2ddca916"><gtr:id>eb045eb004a69a1506f1d58c2ddca916</gtr:id><gtr:otherNames>Abidi SH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1001-0602</gtr:issn><gtr:outcomeId>CEAB1CC8735</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D20C8D97-1DA3-4CA3-960C-3B1895C0D3DF</gtr:id><gtr:title>Reciprocal recognition of an HLA-Cw4-restricted HIV-1 gp120 epitope by CD8+ T cells and NK cells.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c038bff81d22f1b254cc1f518eea7a74"><gtr:id>c038bff81d22f1b254cc1f518eea7a74</gtr:id><gtr:otherNames>Thananchai H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>A5532D807F1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>932DEABA-91F3-43DF-B1F8-CC1356C1E5A6</gtr:id><gtr:title>High pro-inflammatory cytokine secretion and loss of high avidity cross-reactive cytotoxic T-cells during the course of secondary dengue virus infection.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c22f4dff265ae6494e8c07966c893b13"><gtr:id>c22f4dff265ae6494e8c07966c893b13</gtr:id><gtr:otherNames>Dong T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>17543B2715A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>177FE2B4-4D87-4A15-87AB-248F6584F84A</gtr:id><gtr:title>Polyfunctional T cell responses are a hallmark of HIV-2 infection.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f90a66fcd9ab2ce6df6436b14b4eb6d"><gtr:id>6f90a66fcd9ab2ce6df6436b14b4eb6d</gtr:id><gtr:otherNames>Duvall MG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>C4CB6BB1AB7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6D339489-D145-4322-924E-8EF84A6F4F3A</gtr:id><gtr:title>Maternal HLA homozygosity and mother-child HLA concordance increase the risk of vertical transmission of HIV-1.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7a92974f81628ba7317d86afc00bb978"><gtr:id>7a92974f81628ba7317d86afc00bb978</gtr:id><gtr:otherNames>Mackelprang RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>377E24A2589</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13E786B5-F969-4026-80B9-DFD6F1F38B50</gtr:id><gtr:title>Increased frequencies of CD4+ CD25(high) regulatory T cells in acute dengue infection.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/61192e36b6f6c8de0debb1742db9271f"><gtr:id>61192e36b6f6c8de0debb1742db9271f</gtr:id><gtr:otherNames>L?hn K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>E189D6CBF69</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F2F84DA7-7E63-4566-BDCA-086C27F369EE</gtr:id><gtr:title>nef gene sequence variation among HIV-1-infected African children.</gtr:title><gtr:parentPublicationTitle>HIV medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd0efa7d2c265a7c0d011f8d7592dd5d"><gtr:id>fd0efa7d2c265a7c0d011f8d7592dd5d</gtr:id><gtr:otherNames>Chakraborty R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1464-2662</gtr:issn><gtr:outcomeId>E7964874C3A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A8E6FE4A-1CE0-4D59-B8C2-6095066A8835</gtr:id><gtr:title>HV-1-specific cytotoxic T lymphocytes and breast milk HIV-1 transmission.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4b8dce2a24ffa07ac920a59d48a0418d"><gtr:id>4b8dce2a24ffa07ac920a59d48a0418d</gtr:id><gtr:otherNames>John-Stewart GC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>56E2C68A97C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>87A8EE40-1C97-4D52-919E-273D8BDBCD23</gtr:id><gtr:title>Are plasma biomarkers of immune activation predictive of HIV progression: a longitudinal comparison and analyses in HIV-1 and HIV-2 infections?</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7d4bec89b63675f4ca163786a7f26441"><gtr:id>7d4bec89b63675f4ca163786a7f26441</gtr:id><gtr:otherNames>Nyamweya S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_15867_27_22970212</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>71952D88-D378-4BF0-BA92-7C7E2F3843F3</gtr:id><gtr:title>Progress towards a dengue vaccine.</gtr:title><gtr:parentPublicationTitle>The Lancet. Infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/418f248c313956883eafb2fe6ad99932"><gtr:id>418f248c313956883eafb2fe6ad99932</gtr:id><gtr:otherNames>Webster DP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1473-3099</gtr:issn><gtr:outcomeId>Ar1GiFQg8hK</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B7490694-9B41-4299-9D97-EE790480A4A9</gtr:id><gtr:title>Infants with late breast milk acquisition of HIV-1 generate interferon-gamma responses more rapidly than infants with early peripartum acquisition.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/206d12fc9d5b3cee5d6953c028e0b33a"><gtr:id>206d12fc9d5b3cee5d6953c028e0b33a</gtr:id><gtr:otherNames>Lohman-Payne B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0009-9104</gtr:issn><gtr:outcomeId>D191B544ED4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>246B9FF5-FAF9-4E61-AFDA-50C2711673A2</gtr:id><gtr:title>Cutting Edge: Allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c038bff81d22f1b254cc1f518eea7a74"><gtr:id>c038bff81d22f1b254cc1f518eea7a74</gtr:id><gtr:otherNames>Thananchai H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>71AA03BFC82</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U137884180</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>67</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>D8F3A27D-084A-40BB-A046-087DACE23410</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>3.4  Vaccines</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>